UBS Group AG - ALLSCRIPTS HEALTHCARE SOLUTN ownership

ALLSCRIPTS HEALTHCARE SOLUTN's ticker is MDRX and the CUSIP is 01988P108. A total of 248 filers reported holding ALLSCRIPTS HEALTHCARE SOLUTN in Q2 2022. The put-call ratio across all filers is 52.65 and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of ALLSCRIPTS HEALTHCARE SOLUTN
ValueSharesWeighting
Q3 2023$37,016
+34.6%
2,817
+29.0%
0.00%
Q2 2023$27,505
-84.2%
2,183
-83.7%
0.00%
Q1 2023$174,570
-89.4%
13,377
-85.7%
0.00%
-100.0%
Q4 2022$1,646,747
+740.2%
93,353
+622.6%
0.00%
Q3 2022$196,000
-77.0%
12,919
-77.5%
0.00%
Q2 2022$852,000
-39.9%
57,455
-8.7%
0.00%
Q1 2022$1,417,000
+136.6%
62,963
+93.9%
0.00%
Q4 2021$599,000
-24.7%
32,466
-45.3%
0.00%
Q3 2021$795,000
-43.3%
59,391
-21.5%
0.00%
Q2 2021$1,401,000
+112.9%
75,654
+72.7%
0.00%
Q1 2021$658,000
-8.5%
43,798
-12.1%
0.00%
Q4 2020$719,000
-52.4%
49,839
-73.2%
0.00%
-100.0%
Q3 2020$1,512,000
+530.0%
185,756
+423.9%
0.00%
Q2 2020$240,000
-37.5%
35,454
-35.0%
0.00%
Q1 2020$384,000
-82.0%
54,568
-74.9%
0.00%
-100.0%
Q4 2019$2,137,000
-12.8%
217,718
-2.5%
0.00%0.0%
Q3 2019$2,452,000
+82.3%
223,344
+93.2%
0.00%0.0%
Q2 2019$1,345,000
+14.7%
115,610
-6.0%
0.00%
Q1 2019$1,173,000
+8.2%
122,996
+9.4%
0.00%
Q4 2018$1,084,000
-82.2%
112,467
-73.6%
0.00%
-100.0%
Q3 2018$6,083,000
-19.6%
426,817
-32.3%
0.00%
-33.3%
Q2 2018$7,569,000
-31.5%
630,692
-29.5%
0.00%
-40.0%
Q1 2018$11,051,000
+608.9%
894,859
+734.9%
0.01%
+400.0%
Q4 2017$1,559,000
-8.2%
107,178
-10.2%
0.00%0.0%
Q3 2017$1,698,000
-83.6%
119,319
-85.3%
0.00%
-80.0%
Q2 2017$10,346,000
+120.3%
810,792
+118.9%
0.01%
+66.7%
Q1 2017$4,696,000
+193.9%
370,390
+136.6%
0.00%
+200.0%
Q4 2016$1,598,000
-44.7%
156,534
-28.7%
0.00%
-50.0%
Q3 2016$2,892,000
-2.1%
219,571
-5.6%
0.00%0.0%
Q2 2016$2,954,000
-38.6%
232,658
-36.1%
0.00%
-33.3%
Q1 2016$4,812,000
+83.3%
364,301
+113.4%
0.00%
+50.0%
Q4 2015$2,625,000
+57.5%
170,719
+27.0%
0.00%
+100.0%
Q3 2015$1,667,000
-1.4%
134,420
+8.8%
0.00%0.0%
Q2 2015$1,690,000
+31.9%
123,572
+15.4%
0.00%0.0%
Q1 2015$1,281,000
-89.6%
107,109
-88.9%
0.00%
-88.9%
Q4 2014$12,325,000965,1620.01%
Other shareholders
ALLSCRIPTS HEALTHCARE SOLUTN shareholders Q2 2022
NameSharesValueWeighting ↓
Tamarack Advisers, LP 1,500,000$21,593,0004.50%
KESTREL INVESTMENT MANAGEMENT CORP 445,500$6,433,0003.14%
Adirondack Research & Management Inc. 155,088$2,239,0003.06%
SHAPIRO CAPITAL MANAGEMENT LLC 9,398,617$135,716,029,0002.92%
Waterfront Wealth Inc. 136,976$1,978,0001.40%
Smith, Graham & Co., Investment Advisors, LP 1,008,283$14,560,0001.34%
S&T BANK/PA 475,184$6,862,0001.23%
PARADIGM CAPITAL MANAGEMENT INC/NY 1,132,500$16,354,0000.98%
HENNESSY ADVISORS INC 1,024,100$14,788,0000.95%
BEACONLIGHT CAPITAL, LLC 208,546$3,011,0000.91%
View complete list of ALLSCRIPTS HEALTHCARE SOLUTN shareholders